Clinical factors for choosing active surveillance: an analysis of papillary thyroid microcarcinoma patients with recurrence

被引:0
|
作者
Won, Ho-Ryun [1 ,2 ]
Kim, Min Gyu [1 ]
Kim, Min Soo [1 ]
Chang, Jae Won [1 ,3 ]
Koo, Bon Seok [1 ,3 ]
机构
[1] Chungnam Natl Univ, Dept Otorhinolaryngol Head & Neck Surg, Coll Med, Daejeon, South Korea
[2] Chungnam Natl Univ, Dept Otorhinolaryngol Head & Neck Surg, Sejong Hosp, Sejong, South Korea
[3] Chungnam Natl Univ Hosp, Dept Otolaryngol Head & Neck Surg, Daejeon, South Korea
基金
新加坡国家研究基金会;
关键词
thyroid cancer; papillary thyroid microcarcinoma; active surveillance; recurrence; clinical factor; BRAF MUTATION; CANCER; ASSOCIATION; CARCINOMA;
D O I
10.1530/ETJ-23-0195
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: Active surveillance (AS) has been suggested as a management option for low-risk papillary thyroid microcarcinoma (PTMC). However, the currently proposed selection criteria for AS application do not consider various clinical factors. The purpose of this study was to analyze clinical factors related to recurrence that could be confirmed preoperatively in patients who underwent surgery for PTMC and to identify factors worth considering when deciding whether to apply AS. Materials and methods: Data were collected from patients with PTMC who underwent surgical treatment at Chungnam National University Hospital. A retrospective cohort was established according to the presence or absence of recurrence during the follow-up period. In total, 2717 patients were enrolled, of whom 60 experienced recurrence. Various clinical factors that could be identified before surgery were analyzed. Results: The relationship between various clinical factors that could be confirmed preoperatively and recurrence was confirmed through Cox regression analysis and Kaplan-Meier curve analysis. BRAF mutation and the tall cell variant were significantly more common in patients with recurrence. In patients aged 55 years or older, the risk of recurrence was lower than in younger patients, while the recurrence-free survival (RFS) rate was higher. Conclusion: When choosing between surgical treatment or AS in PTMC patients, additional consideration of the patient's clinical factors, such as age and BRAF mutation status, may be required in addition to the existing criteria.
引用
收藏
页数:8
相关论文
共 50 条
  • [1] Clinical Trials of Active Surveillance of Papillary Microcarcinoma of the Thyroid
    Miyauchi, Akira
    WORLD JOURNAL OF SURGERY, 2016, 40 (03) : 516 - 522
  • [2] Clinical Trials of Active Surveillance of Papillary Microcarcinoma of the Thyroid
    Akira Miyauchi
    World Journal of Surgery, 2016, 40 : 516 - 522
  • [3] Active surveillance in papillary thyroid microcarcinoma
    Lamartina, L.
    Leboulleux, S.
    CORRESPONDANCES EN METABOLISMES HORMONES DIABETES ET NUTRITION, 2019, 23 (4-5): : 116 - 118
  • [4] Papillary thyroid microcarcinoma and active surveillance
    Tulchinsky, Mark
    LANCET DIABETES & ENDOCRINOLOGY, 2016, 4 (12): : 974 - 974
  • [5] Papillary thyroid microcarcinoma and active surveillance Reply
    Leboulleux, Sophie
    Tuttle, R. Michael
    Pacini, Furio
    Schlumberger, Martin
    LANCET DIABETES & ENDOCRINOLOGY, 2016, 4 (12): : 976 - 977
  • [6] Patients' View on the Management of Papillary Thyroid Microcarcinoma: Active Surveillance or Surgery
    Yoshida, Yusaku
    Horiuchi, Kiyomi
    Okamoto, Takahiro
    THYROID, 2020, 30 (05) : 681 - 687
  • [7] Active surveillance as a management strategy for papillary thyroid microcarcinoma
    Huan Zhang
    Xiangqian Zheng
    Juntian Liu
    Ming Gao
    Biyun Qian
    Cancer Biology & Medicine , 2020, (03) : 543 - 554
  • [8] Active Surveillance for Papillary Thyroid Microcarcinoma: Challenges and Prospects
    Xue, Shuai
    Wang, Peisong
    Hurst, Zachary A.
    Chang, Yi Seok
    Chen, Guang
    FRONTIERS IN ENDOCRINOLOGY, 2018, 9
  • [9] Active surveillance as a management strategy for papillary thyroid microcarcinoma
    Zhang, Huan
    Zheng, Xiangqian
    Liu, Juntian
    Gao, Ming
    Qian, Biyun
    CANCER BIOLOGY & MEDICINE, 2020, 17 (03) : 543 - 554
  • [10] Active surveillance as a management strategy for papillary thyroid microcarcinoma
    Huan Zhang
    Xiangqian Zheng
    Juntian Liu
    Ming Gao
    Biyun Qian
    Cancer Biology & Medicine, 2020, 17 (03) : 543 - 554